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We investigated the development of pulmonary lesions in ferrets by means of computed
tomography (CT) following infection with the 2009 pandemic A/H1N1 influenza virus and
compared the scans with gross pathology, histopathology and immunohistochemistry. Ground-
glass opacities observed by CT scanning in all infected lungs corresponded to areas of alveolar
oedema at necropsy. These areas were most pronounced on day 3 and gradually decreased from
days 4 to 7 post-infection. This pilot study shows that the non-invasive imaging procedure allows
quantification and characterization of influenza-induced pulmonary lesions in living animals under
biosafety level 3 conditions and can thus be used in pre-clinical pharmaceutical efficacy studies.
The ongoing emergence of novel pathogens (CDC, 2009;
Osterhaus, 2008) calls for the concomitant development of
animal models that address their pathogenesis and assess
the potential of preventive and therapeutic intervention
strategies. For example, the emergence of the 2009
pandemic A/H1N1 influenza virus (pH1N1) highlighted
the need for the rapid development of animal models that
closely mimic the human infection (Itoh et al., 2009;
Osterhaus, 2008; van den Brand et al., 2010). Studies on the
pathogenesis of the disease and the timely assessment of the
efficacy and safety of the rapidly developed vaccine
candidates, antiviral drugs, antibody preparations and
immune modulators, largely depend on newly developed
animal models (Del Giudice et al., 2009; Friesen et al.,
2010; Itoh et al., 2009; van den Brand et al., 2010; Zhou
et al., 2010). However, in these models the assessment of
virus-induced lesions is largely based on findings from an
arbitrarily chosen time point after experimental infection.
When evaluating infections with a peracute onset,
significant early findings may be overlooked unless large
numbers of animals are sacrificed at consecutive time
points. Especially when dealing with outbred animals, like
ferrets, evaluation and integration of consecutive findings
from different animals may be speculative. In addition,
working with highly pathogenic viruses like the pH1N1
virus when it emerged or with the highly pathogenic avian
H5N1 influenza viruses, is limited to biosafety level (BSL)-
3 laboratory settings. The complexity of working under
these stringent restrictions also limits the possibilities to
work with large numbers of animals sacrificed at
consecutive time points. To overcome these limitations
we performed repeated computed tomography (CT) scans
of ferrets under BSL-3 conditions before and during
infection with the pandemic H1N1 influenza (2009) virus.
The pattern of influenza virus attachment and replication
in the ferret respiratory tract is largely similar to that in
humans (Munster et al., 2009; van Riel et al., 2007),
making influenza virus infection of the ferret the model of
choice to study human influenza.
The ferrets (Mustela putorius furo) used were approxi-
mately 8 months of age, females, all seronegative for
antibodies against circulating influenza viruses and for
antibodies against Aleutian disease virus. They were
routinely housed and handled under BSL-3
+ conditions
in negatively pressurized and high efficiency particulate air
(HEPA)-filtered biocontainment isolator units, approved
by an independent institutional laboratory animal ethics
and welfare committee. Animal handling and scans were
performed under general injection anaesthesia (ketamine
12.5 mg kg
21 and medetomidine-HCl 7.5 mg body weight
kg
21). Eight ferrets were inoculated intratracheally with 10
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2009 (pH1N1) as described previously (Del Giudice et al.,
2009; van den Brand et al., 2010). The virus was propagated
in Madin–Darby canine kidney cell cultures and the
infectious dose was determined as described previously
(Munster et al., 2009), and titres calculated according to
the method of Spearman–Karber (Ka ¨rber, 1931). Virus
shedding was monitored daily by collecting nasal and
oropharyngeal swabs that were analysed for determination
of viral loads by standard procedures (van den Brand et al.,
2010), and expressed as log TCID50. All animals had
detectable levels of virus in their upper respiratory tract
(Supplementary Fig. S1, available in JGV Online).
The CT scanner used is a dual-source ultrafast CT system
(Somatom Definition Flash; Siemens Healthcare) with a
temporal resolution of 0.075 s and table speed of
458 mm s
21, the spatial resolution is 0.33 mm. This CT
system requires short acquisition times (#0.22 s) for data
recording of an entire ferret thorax. Such a high temporal
resolution enables accurate scanning of living ferrets
without the necessity of breath holding, respiratory gating
or electrocardiogram (ECG) triggering to generate sharp
images. During in vivo scanning the anaesthetized ferrets
were positioned in dorsal recumbency in a perspex
biosafety container of approximately 8.3 litre capacity that
was purposely designed and built (Tecnilab-BMI)
(Supplementary Fig. S2a, b, available in JGV Online).
The oxygen concentration in the container did not drop
below 14% as measured by oxymetry. All animals had
been scanned 3 days prior to virus inoculation to define
the uninfected baseline status of the respiratory system.
Four ferrets (#3, #4, #5 and #7) were scanned twice (on
days 23 and days 3 or 4), two ferrets (#2 and #8) were
scanned three times (on days 23, 4 and 7) and two ferrets
(#1 and #6) were scanned four times (on days 23, 3, 4 and
7; Supplementary Table S1, available in JGV Online). In
humans, CT-images have been described previously (Gill
et al., 2010; Li et al., 2010; Marchiori et al., 2010; Mollura
et al., 2009; Perez-Padilla et al., 2009) for pulmonary
alterations caused by pandemic (2009) H1N1 influenza
virus infection and the histopathological nature of these
alterations in humans has been evaluated only to limited
extent (Gill et al., 2010; Perez-Padilla et al., 2009). We
found consistent bilateral ground-glass opacities in the
lungs on all time points of scanning. They were most severe
on days 3 and 4 post-infection (p.i.) and showed a
reduction on day 7 (Fig. 1). The post-infectious reductions
in aerated pulmonary volumes were measured from 3D CT
reconstructs using lower and upper thresholds in substance
densities of 2870 to 2430 Hounsfield units (HU). The
mean decrease in aerated lung volumes was most
pronounced on days 3 (26 cm
3) and 4 (24 cm
3) p.i.
compared with day 3 before infection. On day 7 the mean
aerated lung volume returned to, and equalled, baseline
values (31 cm
3) from day 3 before infection (Table 1).
In addition to CT scanning, we also performed magnetic
resonance imaging (MRI) scanning of the ferrets. The MRI
scanner used is a High Definition 3 Tesla clinical scanner
Fig. 1. Two rows of four consecutive 3D lung CT images of ferrets #1 and #6 recorded in vivo under BSL-3
+ compared with
their appearance at necropsy on the far right. At day 3 before infection, the lungs showed the clear aerated baseline condition,
at day 3 p.i. with the new pandemic H1N1 influenza virus marked almost diffuse ground-glass opacities are present that show a
gradual reduction towards 7 days p.i. The two photographs taken at necropsy on 7 days p.i. depict the ventral aspect of the
lungs, within the centre the hearts still attached to the pulmonary hilus. Both lungs show multifocal reddish consolidated areas of
acute inflammation that essentially match with the opacities on the CT images taken just before necropsy; non-affected aerated
lung tissue is light pink in colour.
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times to such a degree that motionless imaging, without the
application of respiratory gating and/or ECG triggering, is
only possible post-mortem. Because of this limitation and
the lower spatial resolution compared with CT scanning, the
MRI scan proved impractical for use in this animal model
and set-up. Accordingly, the MRI results are not presented.
However, MRI scanning under BSL-3 conditions could be of
value to image other organ systems in vivo that are not
hampered by heartbeat or respiratory motion.
Within 1 h after euthanasia by exsanguination from cardiac
puncture (time needed for post-mortem MRI scanning) the
ferrets were submitted for a full necropsy to compare
(histo)pathological data with those that were CT scanned.
Animal #4 succumbed spontaneously on day 3 p.i. and had
to be necropsied without prior MRI scanning. The entire
intact lungs were instilled with, and submerged in 10%
neutral buffered formalin for fixation and disinfection. The
lungs were transversely cut just caudal (approx. 10 mm) of
the tracheal bifurcation and matched to the same transversal
CT image. Additionally from each animal, four similarly cut
left lung sections were made not guided by gross lesions. The
lung sections were routinely processed, paraffin embedded
and 4 mm thin micro-sections were stained with haematox-
ylin and eosin (H&E) for histopathology. All entire slides
were evaluated and scored for the extent of alveolar damage/
alveolitis and for the extent of alveolar oedema (0, 0%; 1,
,25%; 2, 25–50%; and 3, .50%). For the detection of
influenza A virus-infected cells, additionally serial cut
micro-sections were stained for influenza A virus nucleo-
protein (NP) as described previously (van Riel et al., 2007).
The pulmonary ground-glass opacities corresponded on
histology to extensive alveolar oedema admixed with
variable proportions of alveolar macrophages, neutrophils,
erythrocytes, fibrin and cellular debris. Immunohisto-
chemical staining for viral NP showed infected pneumo-
cytes lining the inflamed and flooded alveoli (Fig. 2).
Additionally, there was a moderate necrotizing bronchio-
litis and similar but milder bronchitis. Despite the return
to baseline values in mean aerated lung volumes on day 7
p.i. there were still histological lesions mainly in the form
of mixed inflammatory cellular infiltrates and type II
pneumocyte hyperplasia. Although not statistically sig-
nificant, the median histopathology scores for the extent of
alveolar damage/alveolitis did show a slight decrease from 3
(range 2–3) on day 4 to 2 (range 2–3) on day 7 p.i.
Additionally, matching the improvement in lung aeration
is a significant (P50.031) decrease in the median extent of
alveolar oedema from 3 (range 2–3) on day 4 to 1.5 (range
1–3) on day 7 p.i. (Table 1).
Table 1. Pandemic H1N1 (2009)-induced lung lesions as measured by CT (aerated tissue) and histopathology (alveolar oedema and
alveolar damage)
The aerated lung volumes calculated (used lower and upper thresholds in substance densities: 2870 to 2430 HU) from the 3D CT reconstructs are
presented in cm
3±SD for all animals individually and averaged on the various days. On 7 days p.i., the mean aerated lung volume returns to, and
equals, the mean baseline value on 23 days p.i. of 31 cm
3. Although not statistically significant, the decrease in lung aeration from baseline value on
23 days p.i. of 31 cm
3 to 4 days p.i. 24 cm
3 (P50.20). The median extent of alveolar damage/alveolitis (score range 0–3) shows a slight decrease
from 3 on 4 days p.i. to 2 on 7 days p.i. The median extent of alveolar oedema (score range 0–3) shows a significant (P50.031) decrease from 3 at











232 9 ±2.2 25±0.4 29±2.7 29±1.8 29±1.7 32±1.2 31±1.9 32±1.2 31±4.2D
+32 4 ±3.9 – – D* –2 8 ±1.1 – – 26±3.6
+43 7 ±2.1 17±1.4 31±1.9 – 15±1.5 36±2.7 20±0.2 14±2.2 24±9.6
+74 8 ±2.7 11±1.1 – – – 33±1.8 – 26±2.3 31±14D
Alveolar damage
(score 0–3)
+4 – – 3 (2–3) – 3 (3–3) – 3 (3–3) – 3 (2–3)
+7 2 (2–3) 2 (2–3) – – – 3 (2–3) – 2.5 (2–3) 2 (2–3)
Alveolar oedema
(score 0–3)
+4 – – 2.5 (2–3) – 3 (2–3) – 3 (3–3) – 3 (2–3)d
+7 1 (1–2) 1.5 (1-2) – – – 2 (1–3) – 1.5 (1–2) 1.5 (1–3)d
*Animal #4 died spontaneously at 3 days p.i.
DWilcoxon 23 days p.i. versus +4 days p.i., P50.20.
dMann–Whitney +4 days p.i. versus +7 days p.i., P50.031.
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influenza virus-infected ferrets under BSL-3 conditions by
consecutive in vivo imaging with CT scanning provides
valuable data on disease progression and severity that
closely coincide with post-mortem data obtained at the
same time points from euthanized animals. The ground-
glass opacities observed by CT scanning in all infected
lungs largely corresponded to areas of alveolar oedema
upon necropsy that were most pronounced on days 3 and 4
and decreased towards day 7. As this method involves
repeated CT scans of the same animal instead of sacrificing
multiple animals at different time points, it results in a
refinement of data collection and a significant reduction in
numbers of laboratory animals. In other words the
development of respiratory tract lesions of each individual
animal can be compared with the situation before infection
and followed over time. In this way outbred animals serve
as their own baseline control generating more detailed and
relevant data per animal. In addition, the assessment of the
severity and extent of the lesions over time will lead to
more adequate and objective criteria for the time point of
euthanasia. The ability of this CT-scanning methodology
will not only allow for a more comprehensive study of the
pathogenesis of life-threatening infectious diseases, but also
of the assessment of the efficacy and safety of vaccination
and antiviral strategies against them. In the present pilot
study CT scan opacities correspond to alveolar oedema,
this parameter is among others used as read out in
Fig. 2. Matching CT scan to histopathology of influenza pH1N1-infected ferret #7 on day 4 p.i. (a) Axial CT-image recorded
10 mm caudally of the tracheal bifurcation depicts bilateral pulmonary ground-glass opacities with peribronchovascular pre-
dominance. The rounded white heart shadow (H) is visible in the centre enclosed by the darker lung lobes. During scanning the
ferret is placed in dorsal recumbency on a V-shaped tray. The red frame indicates the approximate location of micrograph (c).
(b) Subgross histological image matching the location of the axial CT-scan. The red frame indicates the exact location of
micrograph (c) (H&E-staining; bar, 10 mm). (c) Low magnification micrograph depicting the histological lesions of the right lung
corresponding to consolidated ground-glass opacities, they are composed of extensively flooded alveoli and thickened alveolar
septa adjacent to a bronchus containing a plug of mucus with few neutrophils and desquamated epithelial cell remnants (arrow).
On top right and middle to bottom left, white non-staining still aerated alveoli are present. The blue frame indicates the exact
location of micrograph (d) (H&E-staining; bar, 1 mm). (d) Micrograph depicting the damaged alveoli characterized by infiltrated
thickened septa and luminal flooding with protein-rich oedema (pink areas) admixed with variable proportions of macrophages,
neutrophils, fibrin, erythrocytes and cellular debris (H&E-staining; bar, 200 mm). Insert on top right: high magnification of serially
cut immunohistochemical slide from the same area of micrograph (d), depicting thickened alveolar septa infiltrated by
neutrophils (arrows) and adjacent dark-brown staining nuclei of influenza virus-infected pneumocytes lining the flooded alveolus
(immunoperoxidase-staining for NP of influenza A virus counterstained with haematoxylin; bar, 40 mm).
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den Brand et al., 2011). Obviously this methodology is not
limited to studying the respiratory tract, but could also be
exploited for new emerging pathogens with their specific
target organs in other animal models.
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